High-Throughput Imaging Assessing Virus-Neutralizing Activity of Sera from Vaccinated Individuals

The severe acute respiratory coronavirus 2 (SARS-CoV-2) has caused the ongoing COVID-19 pandemic, infecting more than 206 million people and causing upwards of 4.34 million deaths at the time of writing.

Taking Advantage of Viral Cytopathic Effects to Aid in the Rapid Screening of Effective Viral Therapies

Virology researchers use CPE effects pathogens elicit on the host to study host-pathogen interactions.

Dissecting the Genetic Code of SARS-CoV-2 with Reverse Genetics

The COVID-19 pandemic has increased SARS-CoV-2 research globally resulting in three publicly available vaccines from Moderna, Pfizer (mRNA-based), and Johnson & Johnson (viral vector-based).

High-throughput Imaging Cytometry as a Powerful Tool for Drug Repurposing

Drug repurposing, also known as drug repositioning is a powerful tool for the rapid expansion of available therapy options by identifying new therapeutic uses from pre-existing drugs.

Science in the Time of COVID-19: Drug Repurposing

Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.

By |2021-06-15T04:17:49+00:00June 22nd, 2020|Categories: Celigo, Instrument, Latest News, Virology|Tags: , , , |0 Comments

Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?

Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.

Go to Top